AV Therapeutics, Inc.: 10-Q filed 2014-08-19
What AV Therapeutics, Inc. reported in its quarterly report filed 2014-08-19 (fiscal Q2 2014): 25 published measures, 73 facts as tagged in accession 0001185185-14-002260.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-08-19
- Fiscal period
- fiscal Q2 2014
- Accession
- 0001185185-14-002260 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AV Therapeutics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 640,206 | USD | |
| At 2013-12-31 | 784,927 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | -602,628 | USD | |
| At 2013-12-31 | 34,172 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 471,084 | USD | |
| At 2013-12-31 | 576,251 | USD | |
| At 2013-06-30 | 91,989 | USD | |
| At 2012-12-31 | 97,436 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 92,368 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -308,509 | USD | 181 |
| 2007-07-24 to 2014-06-30 | -308,509 | USD | 2534 |
| 2013-04-01 to 2013-06-30 | -71,813 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -173,616 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | -626,167 | USD | 181 |
| 2013-01-01 to 2013-06-30 | -180,447 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 0 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 0 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 0 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 0 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 521,000 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 175,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | -5,045,376 | USD | |
| At 2013-12-31 | -4,736,867 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 863 | USD | |
| At 2013-12-31 | 1,079 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 197,602 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 227,602 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 0 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 0 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -569,499 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -970,376 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -71,613 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -173,092 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 501,834 | USD | |
| At 2013-12-31 | 636,251 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 0 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 0 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 200 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 524 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 1,242,834 | USD | |
| At 2013-12-31 | 750,755 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 569,499 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 970,376 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 71,613 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 173,092 | USD | 181 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 69,097 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 121,004 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 18,338 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 29,112 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 179,075 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 294,325 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 33,300 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 60,300 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 81,001,796 | shares | |
| At 2013-12-31 | 72,000,000 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 4,434,648 | USD | |
| At 2013-12-31 | 3,707,680 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 1,295 | USD | |
| At 2013-12-31 | 1,079 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 137,509 | USD | |
| At 2013-12-31 | 147,597 | USD |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 216 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 216 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 5,152 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 10,304 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 5,151 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 10,303 | USD | 181 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 10,088 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 10,087 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 661,867 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 661,867 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -200 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -524 | USD | 181 |
Inspect the source
- Entity
- AV Therapeutics, Inc. / CIK 0001537293
- Captured
- SEC response SHA-256
8f1d9de3a91936bd8f297cc44f5fc9c526f99292fae3683af24f13a3b10f0811
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001537293.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))